Abstract

The Anatomical RecordVolume 304, Issue 12 p. 2898-2898 RetractionFree Access Retraction This article retracts the following: RETRACTED: Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma Ke Wei, Haixia Sun, Xinhui Chen, Qiwang Chen, Yuehong Li, Haihao Wu, Volume 302Issue 11The Anatomical Record pages: 1941-1949 First Published online: July 16, 2019 First published: 28 October 2021 https://doi.org/10.1002/ar.24810AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma, by Ke WEI, Haixia SUN, Xinhui CHEN, Qiwang CHEN, Yuehong LI, and Haihao WU. The above article, published in The Anatomical Record (DOI: 10.1002/ar.24200) is retracted by the Editor-in-Chief, Dr. Heather Smith, with notification to the American Association for Anatomy and Wiley Periodicals LLC. The decision is the result of an investigation based on concerns raised by a third party. The authors were not available for comments. Based on the investigation that revealed issues of scientific integrity in the data, the editors consider the conclusions of the paper substantially compromised. REFERENCE Wei, K., Sun, H., Chen, X., Chen, Q., Li, Y., & Wu, H. (2019 Nov). Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma. Anat Rec (Hoboken), 302(11), 1941– 1949. https://doi.org/10.1002/ar.24200. Volume304, Issue12December 2021Pages 2898-2898 ReferencesRelatedInformation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.